Redeye updates its estimates and valuation after Boreo’s Q2 2026 report.
Redeye updates its estimates and valuation after Boreo’s Q1 2026 report.
Redeye updates its estimates and valuation after Boreo’s Q4 2025 report.
Redeye initiates coverage of Boreo, an emerging serial acquirer primarily focusing on Finland and the Baltics.
Boreo's Q3 2023 net sales of EUR 41m were 6% short of our forecast, while adjusted EBIT ex-PPA of EUR 2.
Boreo reported Q3 adjusted EBIT ex-PPA of EUR 2.9m, 3% above our estimate and 16% above Refinitiv consensus.
Ahead of Boreo’s Q3 report, due on 2 November, we maintain our estimates intact.
Boreo reported Q2 2023 adjusted EBIT excluding PPA of EUR 2.
Boreo reported Q2 adjusted EBIT ex-PPA of EUR 2.4m, 31% above our estimate and 20% above Refinitiv consensus.
Ahead of Boreo's Q2 report, we incorporate the Delfin Technologies acquisition into our estimates and take a slightly more cautious view on ...
Boreo announced this morning acquisition of Delfin Technologies, a Finnish health technology company with EUR 2.
Boreo reported Q1 adjusted EBIT excluding PPA of EUR 2.
Boreo reported Q1 adjusted EBIT ex-PPA of EUR 2.1m, 13% above our estimate and 5% above Refinitiv consensus.
Ahead of Boreo’s Q1, due on 5 May, we maintain our estimates intact.
Boreo reported Q4 adjusted EBIT excluding PPA of EUR 2.
Boreo reported Q4 adjusted EBIT ex-PPA of EUR 2.5m, 10% above our estimate (no consensus).
Boreo will report its Q4 2022 on 3 March 2023. We take a slightly more cautious view, owing to a slower construction market and the exit fro...
Boreo and SANY Europe GmbH have agreed to terminate their excavator dealership agreements in the Finnish and the Swedish markets.
Boreo has conducted three acquisitions since its Q3 report, with aggregated net sales of EUR 6m and EBITDA of EUR 1.
Boreo announced today a bolt-on acquisition to strengthen its Technical Trade business area.
